|
|
||||||||
Gene Rearrangement at the TCR
Locus1
Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
| Abstract |
|---|
|
|
|---|
gene segment
together with 3.6-kb 5' and 0.7-kb 3' flanking sequences was inserted
6.8 kb upstream of the D
1 gene segment in the murine TCR
locus.
Despite its proximity to the D
gene segments and the E
enhancer,
the inserted V
segment underwent VDJ recombination at the same
frequency as the natural copy located 470 kb upstream. However, the
inserted V
segment was no longer under allelic exclusion control as
it recombined at a similar frequency in the presence of a TCR
transgene. These results suggest that while the inserted fragment
contains the necessary cis-regulatory elements for
determining the frequency of V
rearrangement, additional
cis-regulatory elements are required for mediating V
allelic exclusion. Interestingly, most of the inserted V
rearrangements were not transcribed and expressed in the presence of a
TCR
transgene, suggesting that TCR
allelic exclusion can also be
achieved by blocking the transcription of the rearranged gene segments.
These findings provide strong evidence for distinct control of the
frequency and allelic exclusion of V
gene
rearrangement. | Introduction |
|---|
|
|
|---|
locus, recombination occurs at
the
CD4-CD8-CD44-CD25+
stage of thymocyte development (1). In general, D
to
J
rearrangement precedes V
to D
J
rearrangement and occurs
on both alleles, whereas V
to D
J
rearrangement appears to
occur on one allele at a time (2). If the initial
V
D
J
rearrangement is nonproductive, then V
to D
J
rearrangement can proceed on the other allele. If the first
V
D
J
rearrangement is productive, V
to D
J
joining on
the second allele is inhibited. Thus, an individual T cell expresses a
single TCR
-chain, a phenomenon known as allelic exclusion. In
addition, both human and mouse TCR
loci contain multiple V
gene
segments. Although individual V
s are rearranged and expressed at
different frequencies, a given V
gene segment is recombined and
expressed at a constant frequency as most clearly shown in different
mice of the same strain (3). This report investigates the
parameters that regulate the frequency, timing, order, and allelic
exclusion of V
gene rearrangement.
V(D)J recombination at different Ag receptor gene loci is mediated by
the same recombinase machinery and conserved recombination signal
sequences (RSS).4 The
various levels of regulation of V(D)J recombination are thought to be
mediated through the control of accessibility of substrate gene
segments (4, 5). Studies have shown that
cis-regulatory elements that activate transcription of
germline gene segments also promote their recombination accessibility
(reviewed in Refs. 6 and 7). For example,
deletion of the transcriptional enhancer E
from the endogenous
TCR
locus in mice impairs both germline transcription and
rearrangement of D
and J
gene segments (8, 9, 10).
Conversely, inclusion of the E
in recombination substrates promotes
germline transcription as well as rearrangements of both D
to J
and V
to D
J
in transgenic mice (11, 12). In
contrast to the long-range effect of E
, deletion of the germline
promoter PD
1, located immediately upstream of the D
1 gene segment
(13, 14), impairs germline transcription and rearrangement
of the D
1 without affecting germline transcription and rearrangement
of D
2, J
2, and V
gene segments (15, 16).
Similarly, E
is required for rearrangement of all J
gene segments
at the TCR
locus, while T early
promoter is required for the
rearrangement of only proximal J
gene segments (17, 18). Although the precise role of transcription in recombination
accessibility has yet to be elucidated, these findings suggest that
promoter-enhancer interaction may be a general mechanism for targeting
recombination accessibility of specific gene segment.
Assuming that accessibility control applies to the V
gene
rearrangement, at least three types of regulation could be envisioned.
First, the various levels of regulation of V
rearrangement could be
mediated by a single master cis-regulatory element. This
possibility is not likely because it cannot account for the different
frequencies of V
rearrangements. Second, individual V
s could be
regulated separately, for example by their own specific promoters.
Although this kind of regulation can readily account for the different
frequencies of V
rearrangements, it may not be most efficient for
achieving the ordered, stage- and allele-specific V
rearrangement.
The third possibility, a combination of the two extremes, appears to be
more likely. In this scenario, rearrangement of each V
is regulated
by an individual cis element, such as a promoter, as well as
one or more common cis elements, such as enhancers,
analogous to the accessibility control of the D
1 by both PD
1
promoter and E
enhancer. The individual elements may determine the
frequencies of V
rearrangements, while the common element may
control the order, timing, and allelic exclusion of V
gene
rearrangements.
Although transcriptional activation of V
often precedes their
rearrangement and the occurrence of allelic exclusion is associated
with a down-regulation of V
germline transcription (19, 20), studies that examine the role of V
promoter and E
enhancer in V
rearrangement have so far been inconclusive. In
experiments using a TCR
minilocus in transgenic mice, a V
was
shown to recombine in the absence of germline transcription
(21), although the observed rearrangement may have been
promoted by a V
promoter present 2.5 kb upstream in the same
construct. It is also possible that different cis-regulatory
elements in the promoter may function in transcription and
recombination as observed for enhancers (22, 23).
Similarly, the dependence on E
for V
to D
J
rearrangement in
recombination substrates may have been complicated by integration site
influences, concatenation of substrate, and changes in distance and
configuration of V
to D
and E
in the substrate
(24). In E
-/- mice, the
impaired V
to D
J
rearrangement could be a result of a block in
accessibility of V
, or D
, or both. In the absence of E
, the
D
-J
region, but not the V
region, was silent in germline
transcription and resistant to endonuclease treatment
(10), indicating that E
may not directly regulate V
transcription or recombination accessibility. Whether there are
long-range acting cis-regulatory elements for regulating
V
recombination is not known.
To probe the parameters that regulate the different levels of V
rearrangement, we inserted a V
gene segment, together with its
endogenous promoter and RSS, just 6.8 kb upstream of the D
1 gene
segment at the TCR
locus in mice. We found that the inserted V
gene segment recombined at the same frequency as the natural copy but
its rearrangement was no longer inhibited by the presence of a
functional TCR
transgene. These findings support a regulatory
mechanism by which distinct cis-regulatory elements control
the frequency and allelic exclusion of V
rearrangement.
| Materials and Methods |
|---|
|
|
|---|
Homologous recombination in embryonic stem (ES) cells followed
by Cre/loxP-mediated deletion was used to insert a copy of the V
13
gene segment at the SpeI site 6.8 kb upstream of the D
1
gene segment (see Fig. 1
A). Previously, we showed that the
three DNase I-hypersensitive sites within a 3-kb region upstream of
D
1 were required for efficient D
1 rearrangement
(15). The insertion was
4 kb upstream of the most 5'
DNase I-hypersensitive site and was not expected to affect D
1
rearrangement. The inserted 4.8-kb PstI-SnaBI DNA
fragment contains V
13 and 3.6-kb and 0.7-kb flanking sequences at 5'
and 3', respectively, to ensure the inclusion of the endogenous V
13
promoter and RSS. The targeting vector contained, in the following
order, a 5-kb SpeI fragment as the 5' homologous sequences,
the 4.8-kb V
13 fragment, a phosphoglycerate kinase (PGK)
promoter-driven neomycin (neo) resistance gene flanked by loxP sites,
and a 8.4-kb SphI-SmaI fragment as the 3'
homologous sequences (see Fig. 1
A). A PGK promoter-driven
thymidine kinase (tk) gene was inserted upstream of
the 5' homologous sequences. J1 ES cells were transfected with the
targeting construct, and G418 and gancyclovir double-resistant clones
were analyzed by Southern blot to identify homologous recombinants (see
Fig. 1
B). Heterozygous mutant ES cell clones were grown in
high G418 concentrations to select for homozygous mutant ES cell clones
(25). The PGK-neo was deleted by transient
expression of Cre in multiple heterozygous and homozygous mutant ES
cell clones. Homozygous ES cells with or without the inserted
PGK-neo were then transfected with a functionally assembled
TCR
vector (26).
|
-transgenic mice (derived from
the same TCR
construct as used in the transfection) to obtain
transgenic mutant mice. The names and genotypes of various chimeric and
germline mutant mice are as depicted in Table I
|
Abs specific to CD3, CD4, CD8, Thy-1.2, V
2, 4, 6, 7, 8.1/8.2,
9, 10, 12, 13, and 14 were direct conjugates from BD PharMingen (San
Diego, CA). Single-cell suspensions were prepared from lymph nodes and
thymi. A total of 5 x 105 cells were
stained with the appropriate combination of Abs, and 10,00020,000
live cells (propidium iodide negative) were collected for each sample
using a FACSCalibur flow cytometer (BD Biosciences, Mountain View, CA).
Data were analyzed using CellQuest software (BD Biosciences).
CD44+CD4-CD8- thymocytes were purified by complement-mediated lysis followed by cell sorting. A single-cell suspension of whole thymi was washed twice with PBS and resuspended in medium (HEPES-buffered RPMI 1640, supplemented with 5% FCS, L-glutamate, 2-ME, penicillin, and streptomycin) at 2 x 107 cells/ml. Cells were stained with Abs specific for CD4 and CD8 at 2.5 µg/ml for 1 h on ice, pelleted and washed with medium, and resuspended again at 2 x 107 cells/ml. Low-Tox-M Rabbit Complement (CL3051; Cedarlane Laboratories, Hornby, Ontario, Canada) was added at a 1/10 dilution, and the mixture was incubated for 1 h at 37°C with frequent mixing. Cells were then pelleted and washed with medium, and live cells were collected by Ficoll-Paque centrifugation. Cells were then stained with FITC-CD44 and PE-CD25 Abs, and CD44+ cells were sorted by FACS.
Southern and Northern blot analyses
Following overnight digestion with proteinase K, DNA from tails
and single-cell suspensions of lymph nodes or thymi were isolated by
phenol/chloroform extraction and ethanol precipitation. For Southern
blotting analysis, 10 µg of DNA was digested with the appropriate
enzymes, fractionated on a 0.8% agarose gel, and transferred to
-probe filters. Filters were hybridized with
32P-labeled probes and exposed to phosphorimaging
screens. Total RNA was isolated from thymi using RNazol (Biotecx,
Houston, TX), as per the manufacturers instructions. For Northern
blotting analysis, 10 µg of total RNA was fractionated on a 1.2%
formaldehyde agarose gel and transferred to
-probe filters. The
filters were hybridized with 32P-labeled probes
and exposed to phosphorimaging screens. Images were analyzed by
ImageQuant (Molecular Dynamics, Sunnyvale, CA).
PCR and RT-PCR
Nested PCR for measuring V
13 to D
1J
1.1 rearrangement
were performed in a 50-µl reaction containing 0.6 µg of lymph node
DNA, 100 ng of each primer (1 and 4), 0.2 µM of each dNTP, 3.5 mM
MgCl2, 10 mM Tris-HCl, 50 mM KCl (pH
8.3 at 20°C), and 1 U Taq polymerase. Primary reactions
were run for 12 cycles of 15 s at 94°C, 30 s at 61°C, and
2 min at 72°C. Next, 2 µl were transferred from the primary
reactions to new tubes for secondary PCR that were performed with
identical conditions, except with nested primers (2 and 5) and 18
cycles of amplification. Then, 25 µl of secondary PCR were
electrophoresed on a 1.5% agarose gel, transferred to
-probe
membranes, hybridized with 32P-labeled V
13
cDNA probe, and exposed to phosphorimaging screens.
Seminested PCR for amplifying V
12 to D
1J
1.1
rearrangements were performed in a 50-µl reaction using the same
buffers as above, except that primers 3 and 4 were used. Primary
reactions were run for 12 cycles of 15 s at 94°C, 30 s at
61°C, and 2 min at 72°C. Next, 2 µl is transferred
from the primary reactions to new tubes for secondary reactions that
were performed with identical conditions, except with seminested
primers (3 and 5) and 16 cycles of amplification. Then, 25 µl of
secondary PCR were analyzed by Southern blotting as above using a
V
12 cDNA probe.
Seminested PCR for amplifying V
13 to D
1 rearrangements were
performed in a 50-µl reaction using 1.2 µg, DNA, primers 1 and 6,
and the same buffer conditions as described above. Primary reactions
were 25 cycles of 30 s at 94°C, 30 s at 61°C, 2 min at
72°C. Secondary reactions were done using 2 µl of the primary
reactions and the same conditions as above except seminested primers (2
and 6) and 20 cycles of amplification. Then 10 µl of the secondary
reactions were analyzed by Southern blotting as above using a V
13
cDNA probe.
Semiquantitative JAK3 PCR were done as previously described (15). Briefly, reactions were performed in a 50-µl reaction containing 50 ng of DNA, 100 ng of each primer (7 and 8), 0.2 µM of each dNTP, 2 mM MgCl2, 10 mM Tris-HCl, 50 mM KCl (pH 8.3 at 20°C), and 1 U Taq polymerase. Primary reactions were run for 12 cycles of 15 s at 94°C, 30 s at 61°C, and 2 min at 72°C. Next, 2 µl were transferred from the primary reactions to new tubes for secondary PCR that were performed with identical conditions, except with seminested primers 7 and 9, and 25 cycles of amplification. Then, 25 µl of the secondary amplification were loaded on a 1.5% agarose gel and stained with ethidium bromide.
PCR for specifically amplifying V
i to D
1J
1.1 rearrangements
from thymic and lymph node DNA were performed using the Expand High
Fidelity PCR System kit (Boehringer Mannheim, Mannheim, Germany) as per
the manufacturers instructions. A 50-µl PCR contained 0.6 µg DNA,
100 ng of primers 14 and 5, 0.4 µM of each dNTP, 4.5 mM
MgCl2, 10 mM Tris-HCl, 50 mM KCl (pH 8.3 at
20°C), and 1 U of enzyme. An initial heating of reaction mixture at
94°C for 3 min was followed by 10 cycles of 30 s at 94°C,
30 s at 63°C, and 3 min 45 s at 68°C, immediately
followed by 20 cycles of 30 s at 94°C, 30 s at 63°C, and
(3 min 45 s plus 20 s/cycle) at 68°C. Then 25 µl of PCR were
analyzed by Southern blotting as above using a V
13 cDNA probe.
RT-PCR for assaying germline V
13 transcripts were performed using
total RNA from thymi. Reactions were performed in 50 µl using the
One-Tube Titan kit (Boehringer Mannheim) as per the manufacturers
instructions. A cDNA synthesis reaction was performed at 50°C for 30
min using 30 ng total RNA, 1 ng of each primer (10 and 11), and 3.5 mM
MgCl2. Amplification of cDNA was done in the same
reaction tube, using the following conditions: 30 s at 94°C,
30 s at 60°C, 2 min at 72°C, for 22 cycles. Then, 25 µl of
reactions were analyzed by Southern blotting as above using a V
13
cDNA probe.
RT-PCR for assaying immature
-actin transcripts (29)
were performed on total RNA isolated from thymi using the same reaction
conditions as above except using primers 12 and 13. Then 25 µl of
reactions were electrophoresed on a 1.0% gel and stained with ethidium
bromide.
Primer sequences are as follows: 1, 5'-CTGCCATGGGCACCAGGCTTCTTG; 2, 5'-GGCACCAGGCTTCTTGGCTGGGCAG; 3, 5'-GCTGGAGTTACCCAGACACCC; 4, 5'-AGATACTCGAATATGGACACGGAG; 5, 5'-TGGACACGGAGGACATGCTTTGTC; 6, 5'-CAATCTTGGCCTAGCAGGCTGCAG; 7, 5'-CCTCTCAGACCCCACACCTGGCATC; 8, 5'-CCATAGCTGACTCCCCGGTACTTG; 9, 5'-ACGATGAAGTCGCTGTGCAGAGCCTTA; 10, 5'-TCCTTGACACAGTACTGTCTGAAGC; 11, 5'-CTCTGGATACACGCAGCATGGCCT; 12, 5'-CCTAAGGCCAACCGTGAAAAG; 13, 5'-TCTTCATGGTGCTAGGAGCCA; 14, 5'-CACTCGCTGCATCCTACACATAGCGCTC.
| Results |
|---|
|
|
|---|
13 gene segment
At the murine TCR
locus, D
and J
gene segments are
clustered together and are within 18 kb of the E
enhancer. In
contrast, V
gene segments are dispersed over 250 kb and are at least
340 kb away from D
and E
, with the exception of V
14, which is
only 5 kb away from the E
at the 3' end of the locus (Fig. 1
) (30, 31). We inserted a
copy of the V
13 gene segment, called V
i, together with 3.6-kb 5'
and 0.7-kb 3' flanking sequences 6.8 kb upstream of the D
1 at the
TCR
locus through homologous recombination in ES cells (Fig. 1
and
Materials and Methods). Compared with the natural V
13
gene segment, referred to as V
e, which is 470 kb 5' of D
1, V
i
is
70 times closer to D
and E
than V
e on the linear
chromosomal DNA. Heterozygous and homozygous mutant ES cells in the
presence or absence of the PGK-neo cassette were
differentiated into mature T cells by RAG-2-deficient blastocyst
complementation (27). Germline mutant mice with or without
the PGK-neo were also derived. There was no difference
between the results obtained from chimeric mice derived from targeted
ES cells and germline mutant mice. Therefore, no distinction is made
whether analyzed mice were chimeras or germline mutant mice, unless
necessary. A partial list of generated mice and their genotypes is
detailed in Materials and Methods.
Frequency of V
i rearrangement
The relative usage of V
i in recombination was estimated by
comparing the percentages of V
13-expressing T cells between
wild-type and mutant mice. Lymph node cells were stained with an Ab
specific to the pan-T cell marker Thy-1.2 and Abs to V
13, V
6, or
V
14, then analyzed by flow cytometry. In wild-type (+/+) mice, an
average of 2.3% of Thy-1.2+ T cells
expressed V
13 (Fig. 2
and Table II
). In homozygous mutant mice without
the PGK-neo (V
/V
(
neo)),
4.7% T cells were
V
13 positive. The frequencies of V
6, V
14, and other
V
-expressing T cells were similar between wild-type and mutant mice
(Fig. 2
and data not shown), indicating that V
i did not
significantly affect the rearrangement and expression of the endogenous
V
gene segments. Because T cells from V
/V
(
neo) mice had
four copies of the V
13 gene segment compared with two in wild-type T
cells, the increase in percentages of V
13-expressing T cells
correlated with the copy numbers of the V
13 gene segment. Thus,
despite its proximity to D
and E
, V
i appears to be used at the
same frequency as V
e in mature T cells.
|
|
13-expressing T cells were markedly
increased when PGK-neo was left at the insertion site. On
average, 11.0 and 14.0% of lymph node T cells were V
13 positive in
heterozygous +/V
(neo) and homozygous V
/V
(neo) mice,
respectively (Fig. 2
13-expressing T cells. Although the frequency of
V
13-expressing T cells was substantially increased, the frequencies
of other V
-expressing T cells were only slightly and variably
changed (Fig. 2
e rearranged at approximately the same frequency
(
1.15% per allele) in the presence of PGK-neo, the
frequency of V
i rearrangement was 8.7 and 10.7% (
5.35% per
allele) in heterozygous and homozygous mutant mice, respectively,
an increase of
5- to 7-fold. PGK-neo was constitutively
transcribed (data not shown) and was deleted upon V
i rearrangement.
As PGK-neo does not appear to have an intrinsic property in
promoting DNA recombination (see Discussion), the localized
neo transcription and its associated chromatin changes
probably promotes V
i rearrangement, resulting in increased
percentages of V
13-expressing T cells.
|
i rearrangement in the presence or absence of
PGK-neo were confirmed by semiquantitative PCR analyses of
V
13 to D
1J
1.1 rearrangement in DNA from lymph node cells.
Consistent with the results by flow cytometry, the level of PCR product
was substantially higher (
5 fold) in +/V
(neo) mice than in
wild-type and +/V
(
neo) mice, and the level of the amplified
product was similar between +/V
(
neo) mice and wild-type mice
(Fig. 3
13 to
D
J
1.1 rearrangement in DNA from thymus (Fig. 3
i-D
1J
1.1 rearrangement showed that
the expected 4.5-kb product was detected only in thymic and lymph node
DNA from targeted mice, but not wild-type mice (Fig. 3
i is rearranged at the same frequency as V
e,
but its frequency of rearrangement is much higher than that of V
e in
the presence of PGK-neo.
|
i gene segment
To investigate V
i allelic exclusion, we examined the
frequencies of V
13-expressing T cells in the presence of a
functionally assembled TCR
transgene. The TCR
transgene expressed
V
8.2, and the extent of its expression on mature T cells was
monitored by flow cytometry using anti-CD3 and anti-V
8.1/8.2
Abs. In wild-type (+/+) mice,
18% of CD3+ T
cells expressed V
8.1/8.2. In TCR
(tg-5)-transgenic mice on the
+/+, +/V
(
neo), or +/V
(neo) background, over 99% of T cells
expressed the TCR
transgene (Fig. 4
A). In these same mice, the
percentage of V
13-expressing T cells was decreased at least 18-fold
(Fig. 4
, A and B). Similar folds of decrease in
V
4-, V
6-, or V
12-expressing T cells were also observed. Thus,
the expression of the TCR
(tg-5) transgene appears to exclude the
expression of the endogenous V
s as well as V
i.
The same TCR
transgene was also transfected into
V
/V
(
neo) and V
/V
(neo) ES cells, and
allelic exclusion of V
i expression was analyzed in chimeras
derived from ES cell clones. Like tg-5-transgenic mice,
V
13-expressing T cells were reduced
18-fold (from 4.7 to 0.26%)
in chimeras generated with V
/V
(
neo);tg-2 and with
V
/V
(
neo);tg-1 ES cell clones (Fig. 4
, A
and B). However, V
i exclusion was leaky in chimeras
generated with V
/V
(neo);tg-3 and
V
/V
(neo);tg-4 ES cell clones (in the presence of the
neo cassette). For example, in V
/V
(neo);tg-3
chimeras the TCR
transgene was expressed on 97% of T cells and
V
6-expressing T cells were decreased
9-fold, but
V
13-expressing T cells were decreased only 3-fold (from 14 to
4.3%). In fact, 3.7% of T cells expressed both V
13 and the V
8.2
transgene (Fig. 4
A). The leaky V
i exclusion could be
caused by the presence of PGK-neo and/or by different levels
of TCR
transgene expression due to different copies of the transgene
that were integrated at different sites. Nevertheless, even in the
presence of PGK-neo, V
i expression is excluded in over
95% of total T cells by the TCR
transgene.
To verify V
i allelic exclusion at the DNA level, V
13
rearrangement was assayed by PCR in lymph node DNA of various
transgenic mutant mice. In +/+;tg-5 mice, PCR product corresponding to
V
13 to D
1J
1.1 rearrangement was barely detectable (Fig. 3
A, lane 9), indicating allelic exclusion of the
endogenous V
13 and correlating with the results obtained by flow
cytometry. Unexpectedly, a slightly higher levels of V
13
rearrangement were detected in +/V
(
neo);tg-5 mice than
in wild-type or +/V
(
neo) mice (Fig. 3
A,
lanes 1, 3, and 8), although the
mutant mice had <0.13% of V
13-expressing T cells as compared with
2.3% in wild-type mice and 3.5% in +/V
(
neo) mice (Table II
).
Similar levels of V
13 rearrangement were also detected in thymocyte
DNA from the three types of mice (Fig. 3
B). The loss of
exclusion was specific for V
i (V
13) because rearrangement of
V
12 was undetectable in the same DNA from
+/V
(
neo);tg-5 mice (Fig. 3
A, lanes
8 and 9). In the presence of PGK-neo as in
+/V
(neo);tg-5 mice, even higher levels of V
13
rearrangement were detected (Fig. 3
A, lanes 1 and
79). Particularly, in V
/V
(neo);tg-3 and
V
/V
(neo);tg-4 chimeras, where allelic exclusion was
leaky as shown by flow cytometry (Fig. 4
) and by the presence of V
12
rearrangement at the DNA level (Fig. 3
A), the levels of
V
13 rearrangement were
10- to 20-fold higher than those in
wild-type mice (Fig. 3
A, lanes 1, 5,
and 6). Together, these data show that while rearrangements
of endogenous V
are inhibited by the presence of a TCR
transgene,
V
i continues to rearrange at a similar level (
35%) as if in
the absence of the transgene. However, the majority of the rearranged
V
i is not expressed on the cell surface.
To probe the discrepancy between the levels of V
13 rearrangement
detected by PCR and by cell surface V
13 staining, we assayed for
V
13-containing transcripts in total thymic RNA by Northern blotting
analysis. The 1.3-kb mature transcript was readily detected in
wild-type, +/V
(neo), and +/V
(
neo) mice
(Fig. 5
A, lanes
13), with levels of the transcript corresponding to the
percentages of T cells that expressed V
13 in these mice. As
expected, in the presence of the TCR
transgene (tg-5), no mature
transcript was detected in wild-type or mutant mice either in the
presence or absence of PGK-neo (Fig. 5
A,
lanes 46). Germline V
13 transcript, which is around 1.0
kb, was not detected on the Northern blot, but was readily detected by
RT-PCR, even in the presence of the TCR
transgene (Fig. 5
B). These results show that, in the presence of the TCR
transgene, most rearranged V
i is not highly transcribed and
therefore not expressed on the cell surface.
|
i rearrangement
As shown above, in the absence of PGK-neo
and the TCR
transgene, V
i rearranges and expresses like V
e;
however, V
i rearrangement is not inhibited to the same extent as the
endogenous V
s by the TCR
transgene. To determine whether the
leaky V
i allelic exclusion results from an earlier onset of V
i
rearrangement, we assayed the levels V
13 rearrangement in
CD4-CD8-CD44+
thymocytes. Normally,
CD4-CD8- (double negative
or DN) thymocytes progress from
CD44+CD25- to
CD44+CD25+, then to
CD44-CD25+, and finally to
CD44-CD25- phenotype.
TCR
gene rearrangement occurs predominantly at the
CD44-CD25+ stage.
If the onset of V
i rearrangement occurs earlier, one
would expect to detect higher levels of V
13 rearrangement in
CD44+ fraction of DN thymocytes from
+/V
(neo) mice as compared with wild-type mice. Thus,
CD44+ DN thymocytes were purified from wild-type
and +/V
(neo) mice (97% CD44+), and
the levels of V
13 to D
1J
1.1 rearrangement were assayed by
semiquantitative PCR (Fig. 6
A). Quantification of the
intensity of V
13 PCR product and normalization of the input DNA by
JAK3 PCR amplification showed that
10% more V
13 rearrangement
was detected in +/V
(neo) DNA than in wild-type DNA (Fig. 6
A, lanes 5 and 6). Compared with the
levels of V
13 rearrangements in total wild-type thymus, the level of
V
13 rearrangement in the CD44+ fraction was
8- to 10-fold lower (Fig. 6
A, lanes 16).
Because the level of V
13 rearrangement in wild-type thymus is
2.3% of the total V
rearrangement, the overall level of V
13
rearrangement in the CD44+ fraction of
+/V
(neo) thymus is low. Together, these results
demonstrate that V
i is not significantly recombined earlier during T
cell development.
|
13 to D
1 rearrangement,
before D
1-J
rearrangement, in total thymic DNA from various types
of mice by PCR. As expected, virtually no V
13D
1 rearrangement was
detected in wild-type mice or in TCR
-transgenic mice on a wild-type
background (Fig. 6
13D
1 rearrangements were detected in
+/V
(neo) and +/V
(
neo) mice, even in the
presence of the TCR
transgene (Fig. 6
13 to D
1 rearrangements were authentic as shown by
the presence of N region nucleotides and nucleotide deletion in 13
independent PCR products from +/V
(neo) mice (Fig. 6
To quantify the level of V
13D
1 rearrangement, we used as
comparison the total thymic DNA from J
1M2/
mutant mice, in which the D
2-J
2-C
2 region of the TCR
locus
was deleted (32). In J
1M2/
mice, the
allele undergoes both D
1-J
1 and V
-D
1J
1
rearrangements, whereas the M2 allele undergoes only V
-D
1
rearrangement because the 3' D
1 RSS was mutated. It was previously
shown that the M2 allele undergoes diverse V
to D
1 rearrangement
at a frequency of 21% (32). Assuming that
usage of V
13 in J
1M2/
mice is comparable
to that in wild-type mice (2.3%), because the level of V
13D
1
rearrangement in our mutant mice is approximately one-third the level
of V
13D
1 rearrangement observed in
J
1M2/
mice, the percentage of V
i allele
undergoing V
13D
1 rearrangement is 0.16%
[(0.21)(0.023)(0.33) x 100]. Thus, the steady-state level of
V
iD
1 rearrangement in total thymocytes is at least 10 time lower
than V
13D
J
rearrangement in wild-type mice.
| Discussion |
|---|
|
|
|---|
Recombination of V
gene segments is controlled in terms of
frequency, timing, order, and allelic exclusion. Insertion of the
V
13 gene segment 6.8 kb upstream of the D
1 not only dramatically
shortens the distance between the V
and the D
1 gene segment but
also may have removed the V
from regulation by
cis-regulatory elements naturally present in the V
region
(position effect). A role of distance between gene segments and/or
their position in the locus on V(D)J recombination was initially
suggested by observations at the murine IgH locus. It was found that
initial DJH rearrangements preferentially use the
D segments proximal to JH while the
rearrangements of the more distal D segments occur through secondary
rearrangements (33, 34). Similarly,
VH segments that are proximal to
JH are preferentially used in VDJ recombination
during fetal B cell development (35, 36, 37) and tend to
escape allelic exclusion in Igµ-transgenic mice (38).
Recently, it was found that IL-7R was preferentially required for the
rearrangement of the JH-distal but not the
JH-proximal VH gene
segments (39). Because IL-7R-mediated signaling probably
promotes VH rearrangement by modulating
recombination accessibility (40, 41), this finding implies
that different cis-regulatory elements may control
recombination accessibility of the JH-distal and
JH-proximal VH gene
segments (position effect).
If distance between gene segments affects their frequency of
recombination, one would expect that V
i would be preferentially used
in TCR
recombination in our mutant mice. However, our results
clearly show that, in the absence of PGK-neo, V
i is
rearranged at the same frequency as the endogenous copy (Figs. 2
and 3
and Table II
). The failure to detect higher levels of V
i
rearrangement and expression is not because an initial V
i
rearrangement is deleted by a subsequent rearrangement of an upstream
V
to a downstream D
J
or because there is an intrinsic
selection against V
13-expressing T cells. Much higher levels of
V
13 rearrangement and expression were detected if PGK-neo
was left at the insertion site. Our results are consistent with
observations that recombination frequencies of V
gene segments are
not correlated with their distances to the D
s in the TCR
locus
(3). For example, the V
14 gene segment is within 25 kb
of the D
gene segments but is not most frequently recombined and
expressed (3). In contrast, the V
8.2 gene segment,
which is used with the highest frequency in TCR
rearrangement, is
not the most proximal to the D
-J
region (30, 31).
V
8.2 is highly transcribed during early T lymphocyte development
(42, 43), suggesting that local accessibility of V gene
segments is probably more important in regulating recombination
frequency (see below). In our targeted insertion, although we cannot
exclude unequivocally a role of distance between V
i and D
in
V
i rearrangement, our results are consistent with the interpretation
that position of V
gene segments in the locus, and therefore their
control by cis-regulatory elements, influences the V
gene
rearrangement.
Local regulation of V
recombination frequency
The fact that V
i recombines at the same frequency as the
endogenous copy suggests that the inserted DNA fragment contains the
necessary cis-regulatory elements for regulating the
frequency of V
13 rearrangement. A potential
cis-regulatory element in the inserted fragment is the V
promoter. Although V
promoters have not been shown to promote V
rearrangement, cis elements upstream of the V
gene
segment, corresponding to the likely promoter, control the timing of
V
rearrangement during development (44). Consistent
with the promoter control of V
recombination frequency, the presence
of the PGK-neo transcriptional cassette at the insertion
site resulted in a 5- to 7-fold increase in V
i usage in
recombination (Fig. 3
and Table II
). The stimulating effect of
PGK-neo on V
i rearrangement is in contrast to the
inhibitory effect of the neo cassette on recombination when
inserted into IgH and Ig
loci. Insertion of a PMC1neo
downstream of Ig
intronic enhancer severely blocked V
to J
rearrangement upstream (45). Insertion of
PGK-neo in between the 3' IgH enhancer and constant region
exons blocks class switch recombination to the constant genes 5' of the
neo cassette (46). As PGK-neo does
not have an intrinsic property in promoting recombination, its effect
on V
i rearrangement likely reflects the mechanisms by which V
gene segments are normally targeted for recombination. The neo
transcription is driven by a constitutively active PGK promoter, and
the entire cassette is deleted after V
i recombination. Recent
studies have shown that transcriptional coactivators possess histone
acetyltransferase activity (47, 48, 49) and histone
acetylation is tightly correlated with V(D)J recombination
accessibility (50). The transcription process itself also
leads to changes in DNA-nucleosome interaction (51).
Together, these findings suggest that chromatin changes, mediated by
local cis-regulatory elements, probably determine V
recombination frequency.
Why is V
i not recombined more frequently as its promoter is much
closer to E
? An explanation is suggested by recent findings on the
extent of E
and PD
1 in controlling the chromatin structure of the
TCR
locus. We have shown previously that three DNase
I-hypersensitive sites are present within 3 kb of D
1 gene segment
(19) and the site immediately upstream of D
1
corresponds to the PD
1 promoter (13, 14). In the
presence of PD
1 promoter, the promoter region as well as the
downstream D
1-J
1 region are hypomethylated in developing T cells,
whereas the upstream region including at least one DNase
I-hypersensitive site is hypermethylated (16). Deletion of
PD
1 alone or plus the two upstream hypersensitive sites results in
the invasion of hypermethylation into the downstream D
1-J
1
region. These findings suggest that there is probably a boundary
between the inaccessible upstream region and the accessible D
1-J
1
region. Consistent with this interpretation, deletion of the E
resulted in the hypermethylation, histone hypoacetylation, resistance
to endonuclease treatment, and transcriptional silencing of the
D
-J
region, whereas no significant effect was observed in the
V
region or 5 kb upstream of the D
1 gene segment
(10). Thus, the chromosomal domain regulated by E
appears to be limited to the D
-J
region. Although V
i is much
closer to the D
1 gene segment and E
enhancer, it probably still
resides within a relatively inaccessible region and outside the
E
-regulatory domain, accounting for the absence of a higher level of
V
i rearrangement.
Long-range regulation of V
allelic exclusion
We found that V
i was rearranged at a similar level in the
absence or presence of a TCR
transgene (Fig. 3
), indicating that
V
i is no longer subject to allelic exclusion. The lack of V
i
allelic exclusion cannot be attributed significantly to an earlier
onset of V
i rearrangement because there is only a slight increase of
V
13 rearrangement at the CD44+ DN stage (Fig. 6
). However, the presence of V
to D
rearrangement before
D
-J
rearrangement may have contributed to the lack of V
i
allelic exclusion (Fig. 6
). Because the D
-J
region remains
accessible to the recombinase in double-positive thymocytes
(15), V
D
rearrangements likely undergo further
V
D
-J
rearrangements when the recombinase is re-expressed in
double-positive thymocytes for TCR
rearrangement. Although 0.16% of
V
D
rearrangement is relatively low as compared with 25% V
i
rearrangement in the presence of a TCR
transgene, the amount
represents the steady-state level but does not take into account the
rate of V
D
generation and the rate of conversion to V
D
J
.
Based on these considerations, V
D
rearrangement before D
J
rearrangement probably has contributed to the V
i rearrangement in
the presence of a TCR
transgene, but whether it can account for all
V
i rearrangement is not clear.
As discussed above, the inserted DNA fragment contains
cis-regulatory elements for determining the frequency of
V
13 rearrangement. The similar level of V
i rearrangement in the
presence of a TCR
transgene suggests that the same cis
elements are insufficient for mediating V
i allelic exclusion. There
are likely other cis-regulatory element in the V
region
that normally mediate V
allelic exclusion, and insertion of the
V
13 gene segment in the proximity of D
-J
region may have moved
the V
i outside the regulatory range of these additional
cis-regulatory elements. It is possible that each V
has
its own cis elements for mediating allelic exclusion and
these elements happen not to be included in the inserted fragment.
However, it seems more likely that a few V
s or all V
s share
common cis elements for allelic exclusion (see
Introduction). While the nature and location of these
cis-regulatory elements are unknown, the continuous V
i
rearrangement at a similar frequency in the presence of a TCR
transgene strongly suggests that the frequency and allelic exclusion of
V
rearrangement is regulated by distinct cis-regulatory
elements.
Interestingly, most of the rearranged V
i was not expressed on the
cell surface in the presence of a TCR
transgene (Figs. 4
and 5
). T
cells have been shown to be capable of expressing two different
TCR
-chains simultaneously (52). Similarly, in our
mutant mice, some T cells expressed both V
13 and V
8.2 (Fig. 4
),
suggesting that T cells expressing V
13 and V
8.2 are not
intrinsically selected against. The lack of cell surface expression of
the rearranged V
i in the presence of a TCR
transgene is because
the rearranged V
i is not highly transcribed (Fig. 5
). During normal
thymocyte development, transcription of the rearranged allele is
up-regulated following recombination (53). This apparently
did not occur in most of the developing T cells in which V
i
underwent rearrangement in the presence of a TCR
transgene. While
further studies are required to elucidate the mechanism of this
regulation, the present findings clearly show that allelic exclusion
can be mediated functionally by inhibiting transcription of a
rearranged gene segment.
Regulation of the timing and order of V
rearrangement
In addition, we found a low level of V
i to D
rearrangement
occurring before D
-J
rearrangement and a small increase of V
rearrangement in CD44+ DN thymocytes in the
mutant mice as compared with the wild-type mice. Recently, it was shown
that the 5' RSS of D
1 plays an important role in the ordered
D
J
before V
D
J
rearrangements (54). Although
our findings could result from the close proximity of V
i to the
D
-J
region, we favor the notion that the V
i is removed from
the regulation by additional cis-regulatory elements
normally present in the V
region. In this scenario, the significant
increase of V
i to D
joining in mutant mice would suggest that
these additional cis-regulatory elements may also contribute
to the ordered TCR
rearrangement.
| Acknowledgments |
|---|
genomic fragments; Drs. Barry Sleckman and Fred
Alt for TCR
-transgenic mice and thymic DNA from
J
1M2/
mice; Dr. Yoichi Shinkai for the TCR
transgene construct; and Drs. Jim Haber, Herman Eisen, and Marjorie
Oettinger for critical reading of the manuscript. | Footnotes |
|---|
2 Current address: Department of Molecular Biology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114. ![]()
3 Address correspondence and reprint requests to Dr. Jianzhu Chen, Center for Cancer Research, Massachusetts Institute of Technology, E17-128, 40 Ames Street, Cambridge, MA 02139. E-mail address: jchen{at}mit.edu ![]()
4 Abbreviations used in this paper: RSS, recombination signal sequence; ES, embryonic stem; PGK, phosphoglycerate kinase; neo, neomycin; RAG, recombination-activating gene; DN, double negative. ![]()
Received for publication April 27, 2001. Accepted for publication June 5, 2001.